Breast Cancer Research We're Watching for at ASCO 2026

The 2026 ASCO Annual Meeting, which takes place from May 29 to June 2 in Chicago, attracts thousands of people engaged in all aspects of cancer research, care, and advocacy. The American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people diagnosed with cancer. The organization aims to conquer cancer through research and education.
Breast cancer session topics include stereotactic body radiation for oligometastatic disease, optimizing breast cancer survivorship, and what to do with the results of ctDNA testing for early-stage breast cancer. There will also be updates on treatments for metastatic triple-negative breast cancer, including using Datroway (chemical name: datopotamab deruxtecan or Dato-DXd) as a first treatment, rather than chemotherapy.
Breastcancer.org will be reporting on the latest breast cancer news from the ASCO conference, as well as podcasting with advocates and experts.
Stay tuned to this page for the latest news from #ASCO26.
This content is made possible by Lilly.